IHS Chemical Week

Markets :: Fine Chemicals/Biotech :: Pharmaceutical ingredients

ScinoPharm Signs API Manufacturing Deal with Clinical Data

11:39 PM MST | February 13, 2011 | Deepti Ramesh

Active pharmaceutical ingredients (APIs) manufacturer and contract research and manufacturing services (CRAMS) company ScinoPharm (Shan-Hua, Taiwan) says it will provide commercial manufacturing service for vilazodone hydrochloride API for Clinical Data’s (Newton, MA) Viibryd. Viibryd is a new drug entity recently approved by the U.S. Food and Drug Administration for the treatment of major depressive disorder in adults. ScinoPharm says it is set to expand its CRAM services through its new plant at Changshu, China, which is expected to be operational in the...

This information is only available to Chemical Week subscribers.

Username:
Password:

Forgot your user ID or password?
Click here to have it sent to you.

Risk Free Trial

Email Address

First Name

Last Name

Click here to register and get your RISK-FREE access to chemweek.com

Not an IHS Chemical Week
24/7 member yet?

Here's why you should be:

  • Searchable online archive access of the last 2 years of Chemical Week.
  • Print or digital magazine subscription
  • Price and market change alerts
  • Economic data and statistics
  • Buyers' Guides
  • Webcasts | whitepapers

 

 

 













 
contact us | about us | customer care | privacy policy | sitemap | advertise

ihsCopyright © 2014 IHS, Inc. All rights reserved. Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa